Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nachury, Maria"'
Autor:
Dulai, Parambir S., Amiot, Aurélien, Peyrin-Biroulet, Laurent, Jairaith, Vipul, Serrero, Mélanie, Filippi, Jérome, Singh, Siddharth, Pariente, Benjamin, Loftus, Edward V., Roblin, Xavier, Kane, Sunanda, Buisson, Anthony, Siegel, Corey A., Bouhnik, Yoram, Sandborn, William J., Lasch, Karen, Rosario, Maria, Feagan, Brian G., Bojic, Daniela, Trang-Poisson, Caroline, Shen, Bo, Altwegg, Romain, Sands, Bruce E., Colombel, Jean-Frederic, Carbonnel, Franck, Kochhar, Gursimran, Meserve, Joseph, Barsky, Maria, Boland, Brigid S., Gagniere, Charlotte, Bigard, Marc-André, Zallot, Camille, Grimaud, Jean-Charles, Hebuterne, Xavier, Nachury, Maria, Desreumaux, Pierre, del Tedesco, Emilie, Bommelaer, Gilles, Koliani-Pace, Jenna L., Stefanescu, Carmen, Boureille, Arnaud, Hirten, Robert, Ungaro, Ryan, Vaysse, Thibaud, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Hudesman, David, Chang, Shannon, Bourrier, Anne, Seksik, Philippe, Beaugerie, Laurent, Cosnes, Jacques, Sokol, Harry, Landman, Cécilia, Lukin, Dana, Weiss, Aaron, Marteau, Philippe, Dray, Xavier, Nancey, Stephane, Boschetti, Gilles, Laharie, David, Poullenot, Florian, Allez, Matthieu, Gornet, Jean-Marc, Baudry, Clautilde, Savoye, Guillaume, Moreau, Jacques, Vuitton, Lucine, Koch, Stéphane, Viennot, Stéphanie, Aubourg, Alexandre, Picon, Laurence, Pelletier, Anne-Laure, Sickersen, Gaelle, Bouguen, Guillaume, Abitbol, Vered, Chaussade, Stanislas, Nahon, Stéphane, Fumery, Mathurin, Winkfield, Betsy, Brixi-Benmansour, Hedia, Gincul, Rodica, Barberis, Jean-Christophe, Bonaz, Bruno, Michiels, Christophe, Zerbib, Frank, Beauregard, Marie Bourrier, Locher, Christophe, Davin-Couve, Sophie, Poirette, Armelle, Guillem, Laurence, Stetiu-Mocanu, Monica, Philippe, Beau, Beorchia, Sylvain, Al Qaddi, Jawad, Swaminath, Arun, Observ-Ibd, Getaid, Collaboration, Victory Cohorts
Publikováno v:
Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, 2020, 51 (5), pp.553-564. ⟨10.1111/apt.15609⟩
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology and Therapeutics, 2020, 51 (5), pp.553-564. ⟨10.1111/apt.15609⟩
Alimentary Pharmacology & Therapeutics
International audience; Background A clinical decision support tool (CDST) has been validated for predicting treatment effectiveness of vedolizumab (VDZ) in Crohn's disease. Aim To assess the utility of this CDST for predicting exposure-efficacy and
Autor:
Julien, Clément, Anakok, Emré, Treton, Xavier, Nachury, Maria, Nancey, Stéphane, Buisson, Anthony, Fumery, Mathurin, Filippi, Jérôme, Maggiori, Léon, Panis, Yves, Zerbib, Philippe, François, Yves, Dubois, Anne, Sabbagh, Charles, Rahili, Amine, Seksik, Philippe, Allez, Matthieu, Lefevre, Jérémie, Cattan, Pierre, Chirica, Mircea, Munoz-Bongrand, Nicolas, Corte, Hélène, Beaupel, Nathan, Catry, Jonathan, Gornet, Jean-Marc, Baudry, Clotilde, Lourenco, Nelson, Maillet, Mariane, Tran-Minh, My-Linh, Chardiny, Victor, Bonnet, Joelle, Chedouba, Leila, Nisard, Andrée, Beaugerie, Laurent, Bourrier, Anne, Nion-Larmurier, Isabelle, Kirchgesner, Julien, Landman, Cécilia, Quevrain, Elodie, Brot, Loic, Chafai, Najim, Parc, Yann, Debove, Clothilde, Svreck, Magali, Vincent, Camille, Guedj, Nathalie, Ferron, Marianne, Bouhnik, Yoram, Corcos, Olivier, Stefanescu, Carmen, Khabil, Sarah, Marteau, Philippe, Dray, Xavier, Chaput, Ulrika, Bommelaer, Gilles, Goutte, Marion, Denizot, Jérémie, Barnich, Nicolas, Coban, Dilek, Desreumaux, Pierre, Pariente, Benjamin, Sommeville, Coralie, Dupas, Jean-Louis, Loreau, Julien, Brazier, Franck, Chatelain, Denis, Attencourt, Christophe, Leconte, Martine, Boschetti, Gilles, Flourié, Bernard, Cotte, Eddy, Charlois, Anne-Laure, Falgon, Peggy, Hadjisavvas, Helena, Moussata, Driffa, Chauvenet, Marion, Boyer, Sarah, Hebuterne, Xavier, Arab, Nadia, Barhoumi, Raja, Hofmann, Paul, Le Corff, Sylvain, Bonnet, Anna, Beyer-Berjot, Laura, Sokol, Harry
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, 2022, 16 (8), pp.1211-1221. ⟨10.1093/ecco-jcc/jjac026⟩
Journal of Crohn's and Colitis, 2022, 16 (8), pp.1211-1221. ⟨10.1093/ecco-jcc/jjac026⟩
Background and Aims Surgery is performed in 50–70% of Crohn’s disease [CD] patients, and its main risk is surgical site infection [SSI]. The microbiota has been extensively assessed in CD but not as a potential risk factor for septic morbidity. T
Autor:
Tadbiri, Sara, Nachury, Maria, Bouhnik, Yoram, Serrero, Melanie, Hébuterne, Xavier, Roblin, Xavier, Kirchgesner, Julien, Bouguen, Guillaume, Franchimont, Denis, Savoye, Guillaume, Buisson, Anthony, Louis, Edouard, Nancey, Stephane, ABitbol, Vered, Reimund, Jean-Marie, DeWit, Olivier, Vuitton, Lucine, Matthieu, Nicolas, Peyrin-Biroulet, Laurent, Gilletta, Cyrielle, Allez, Matthieu, Viennot, Stephanie, Trang-Poisson, Caroline, Dib, Nina, Brixi, Hedia, Boualit, Medina, Plastaras, Laurianne, Boivineau, Lucile, Fumery, Mathurin, Caillo, Ludovic, Laharie, David, Amiot, Aurelien, GETAID-IBD-disk study group
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, 2021, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Journal of Crohn's & colitis, Vol. 15, no.5, p. 766-773 (2021)
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Journal of Crohn's and Colitis, 2021, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Journal of Crohn's & colitis, Vol. 15, no.5, p. 766-773 (2021)
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, 15 (5), pp.766-773. ⟨10.1093/ecco-jcc/jjaa244⟩
Background and Aim The inflammatory bowel disease [IBD]-disk is a 10-item self-questionnaire that is used to assess IBD-related disability. The aim of the present study was to evaluate this tool in the assessment of IBD daily-life burden. Methods A 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a44ccd22ada0c96bf93ce63641fd0b
https://hal.science/hal-03038348/document
https://hal.science/hal-03038348/document
Autor:
Reenaers, Catherine, Mary, Jean-Yves, Nachury, Maria, Bouhnik, Yoram, Laharie, David, Allez, Matthieu, Fumery, Mathurin, Amiot, Aurélien, Savoye, Guillaume, Altwegg, Romain, Devos, Martine, Malamut, Georgia, Bourreille, Arnaud, Flourie, Bernard, Marteau, Philippe, Vuitton, Lucine, Coffin, Benoit, Viennot, Stéphanie, Lambert, Jérôme, Colombel, Jean-Frédéric, Louis, Edouard, Getaid, Groupe d'Etude Thérapeutique Des Affections
Publikováno v:
Clinical Gastroenterology and Hepatology
Clinical Gastroenterology and Hepatology, WB Saunders, 2018, 16 (2), pp.234-243.e2. ⟨10.1016/j.cgh.2017.09.061⟩
Clinical Gastroenterology and Hepatology, WB Saunders, 2018, 16 (2), pp.234-243.e2. ⟨10.1016/j.cgh.2017.09.061⟩
Background & Aims Little is known about long-term outcomes of patients with Crohn's disease (CD) after infliximab withdrawal. We aimed to describe the long-term outcomes of patients with CD in clinical remission after infliximab treatment was withdra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ac20db463fa7ca98f121dc67de4e49
https://hal-normandie-univ.archives-ouvertes.fr/hal-02332318
https://hal-normandie-univ.archives-ouvertes.fr/hal-02332318
Autor:
Bourrier, A., Carrat, F., Colombel, F., Bouvier, A., Abitbol, Vered, Marteau, P., Cosnes, J., Simon, T., Peyrin-Biroulet, Laurent, Beaugerie, L., Carbonnel, Franck, Colombel, Jean Frédéric, Filippi, Jérôme, Katsanos, Konstantinos, Allez, Mathieu, Nachury, Maria, Novacek, Gottfried, Danese, Silvio, Bossa, Fabrizio, Moreau, Jacques, Bommelaer, Gilles, Bourreille, Arnaud, Fumery, Mathurin, Roblin, Xavier, Reinisch, Walter, Bouhnik, Yoram, Brixi, Hedia, Seksik, Philippe, Malamut, Georgia, Färkkilä, Martti, Coulibaly, Baya, Dewit, Olivier, Louis, Edouard, Deplanque, Dominique, Michetti, Pierre, Sarter, Hélène, Laharie, David, Demolin, Julie, Détré, Patricia, Brillaut, Gaëlle
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261. ⟨10.1111/apt.13466⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261 〈10.1111/apt.13466〉
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261. ⟨10.1111/apt.13466⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261
Alimentary Pharmacology & Therapeutics (Suppl), 2016, 43 (2), pp.252-261 〈10.1111/apt.13466〉
Background The risk of urinary tract cancers, including kidney and bladder cancers, was increased in transplant recipients receiving thiopurines. Aim To assess the risk of urinary tract cancers in patients with inflammatory bowel disease (IBD) receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b20ad1a1c3ecca9b0b3e16eadc72f35
https://hal.science/hal-02013807
https://hal.science/hal-02013807
Autor:
Poullenot, Florian, Seksik, Philippe, Beaugerie, Laurent, Amiot, Aurélien, Nachury, Maria, Abitbol, Vered, Stefanescu, Carmen, Reenaers, Catherine, Fumery, Mathurin, Pelletier, Anne-Laure, Nancey, Stéphane, Peyrin-Biroulet, Laurent, Bourreille, Arnaud, Hébuterne, Xavier, Brixi, Hedia, Savoye, Guillaume, Lourenço, Nelson, Altwegg, Romain, Buisson, Anthony, Cazelles-Boudier, Christine, Racine, Antoine, Vergniol, Julien, Laharie, David, Getaid, Groupe d'Etude Thérapeutique Des Affections
Publikováno v:
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, 2016, 22 (6), pp.1362-1369. ⟨10.1097/mib.0000000000000741⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1362-1369. ⟨10.1097/mib.0000000000000741⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1362-1369. ⟨10.1097/MIB.0000000000000741⟩
Inflammatory Bowel Diseases, 2016, 22 (6), pp.1362-1369. ⟨10.1097/mib.0000000000000741⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1362-1369. ⟨10.1097/mib.0000000000000741⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2016, 22 (6), pp.1362-1369. ⟨10.1097/MIB.0000000000000741⟩
International audience; Background:Patients with inflammatory bowel disease (IBD) and history of malignancy within the last 5 years are usually contraindicated for receiving anti-tumor necrosis factor (anti-TNF) agents. The aim of this study is to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb2b45516ba02b3cab516f6fac92c4e
https://normandie-univ.hal.science/hal-02326930
https://normandie-univ.hal.science/hal-02326930
Autor:
Julian Panés, Gerd Bouma, Marc Ferrante, Torsten Kucharzik, Maria Nachury, Fernando de la Portilla de Juan, Walter Reinisch, Francesco Selvaggi, Jörg Tschmelitsch, Neil R Brett, Martin Ladouceur, Matthias Binek, Gary Hantsbarger, Sarah Campbell-Hill, Chitra Karki, Christianne Buskens
Publikováno v:
Inflammatory Bowel Diseases, 28(11), 1737-1745. John Wiley and Sons Inc.
Panés, J, Bouma, G, Ferrante, M, Kucharzik, T, Nachury, M, de la Portilla de Juan, F, Reinisch, W, Selvaggi, F, Tschmelitsch, J R, Brett, N R, Ladouceur, M, Binek, M, Hantsbarger, G, Campbell-Hill, S, Karki, C & Buskens, C 2022, ' INSPECT : A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial ', Inflammatory Bowel Diseases, vol. 28, no. 11, pp. 1737-1745 . https://doi.org/10.1093/ibd/izab361
Panés, J, Bouma, G, Ferrante, M, Kucharzik, T, Nachury, M, de la Portilla de Juan, F, Reinisch, W, Selvaggi, F, Tschmelitsch, J R, Brett, N R, Ladouceur, M, Binek, M, Hantsbarger, G, Campbell-Hill, S, Karki, C & Buskens, C 2022, ' INSPECT : A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial ', Inflammatory Bowel Diseases, vol. 28, no. 11, pp. 1737-1745 . https://doi.org/10.1093/ibd/izab361
Background The efficacy of a single administration of darvadstrocel (expanded allogeneic adipose-derived mesenchymal stem cells) for treating complex perianal fistulas in patients with Crohn’s disease was demonstrated in a randomized, double-blind
Autor:
Christos Tzivinikos, Ibrahim Shamasneh, Marina Aloi, Patrizia Alvisi, Erasmo Miele, Rémi Duclaux-Loras, Jérôme Viala, Stéphanie Willot, Rosa Lima, Claire Dupont-Lucas, Mario Mašić, Julie Lemale, Daniela Prlenda-Touilleux, J. Languepin, Sanja Kolaček, Chrystèle Madre, Alexandre Fabre, Kaija-Leena Kolho, Charlotte Bergoin, Sibylle Koletzko, Jean-Pierre Hugot, Raphaël Enaud, Christine Martinez-Vinson, Maria Nachury, Alexis Mosca, Annecarin Brueckner, Emmanuelle Dugelay
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition
Journal of Pediatric Gastroenterology and Nutrition, 2021, 73 (3), pp.333-337. ⟨10.1097/MPG.0000000000003200⟩
Journal of Pediatric Gastroenterology and Nutrition, 2021, 73 (3), pp.333-337. ⟨10.1097/MPG.0000000000003200⟩
International audience; Objectives: Digestive perianastomotic ulcerations (DPAU) resembling Crohn disease lesions are long-term complications of intestinal resections, occurring in children and young adults. They are known to be uncommon, severe and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c4736ccad355f64afe331d90870a03
https://amu.hal.science/hal-03662735
https://amu.hal.science/hal-03662735